SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-005944
Filing Date
2021-01-20
Accepted
2021-01-20 19:02:39
Documents
2
Period of Report
2021-01-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211948-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm211948-5_4seq1.xml 4 3977
2 EXHIBIT 24 tm211948d5_ex24.htm EX-24 8801
  Complete submission text file 0001104659-21-005944.txt   14239
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Huber Martin H. Jr. (Reporting) CIK: 0001653276 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 21539980